Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

G. Holz, Frank; Tadayoni, Ramin; Beatty, Stephen; R. Berger, Alan; Giuseppe Cereda, Matteo; Cortez, Rafael; B. Hoyng, Carel; Hykin, Philip; Staurenghi, Giovanni; Heldner, Stephanie; Bogumil, Timon; Heah, Theresa; Sivaprasad, Sobha

doi:10.1136/bjophthalmol-2014-305327

Public

Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration

Published in British Journal of Ophthalmology • Sep 5, 2014

Authors:

Frank G. Holz

Ramin Tadayoni

Stephen Beatty

Abstract

BACKGROUND/AIMS: Real-life anti-vascular endothelial growth factor (VEGF) therapy use in patients with wet age-related macular degeneration (wAMD) was assessed in a retrospective, observational study in Canada, France, Germany, Ireland, Italy, the Netherlands, UK and Venezuela. METHODS: Medical reco...

Subject

Medicine

Visual acuity

Ranibizumab

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!